ESR2 and neoplasm: It mediated anti‐carcinogenic activity through restrictions on the proliferation of cells and tumor cell growth via upregulating estrogen receptor beta (ER‐β) and downregulating of 1R insulin‐like growth factor 1 (IGF‐1) in MCF‐7 and T‐47D cell in a dose‐dependent way.58